Novavax, Inc.
Coronavirus vaccine formulations

Last updated:

Abstract:

Disclosed herein are coronavirus Spike (S) proteins and nanoparticles comprising the same, which are suitable for use in vaccines. The nanoparticles present antigens from pathogens surrounded to and associated with a detergent core resulting in enhanced stability and good immunogenicity. Dosages, formulations, and methods for preparing the vaccines and nanoparticles are also disclosed.

Status:
Grant
Type:

Utility

Filling date:

18 Mar 2021

Issue date:

22 Feb 2022